Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Arimoclomol Prospective Study in Patients Diagnosed With NiemannPick Disease Type C

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02612129
Recruitment Status : Active, not recruiting
First Posted : November 23, 2015
Last Update Posted : May 20, 2019
Sponsor:
Information provided by (Responsible Party):
Orphazyme

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : June 20, 2018
  Estimated Study Completion Date : October 2020
  Certification/Extension First Submitted : May 14, 2019